This topic contains a solution. Click here to go to the answer

Author Question: Quasi-experimental designs are different from low-constraint methods in that A) ... (Read 54 times)

Pineapplelove6

  • Hero Member
  • *****
  • Posts: 560
Quasi-experimental designs are different from low-constraint methods in that
 
  A) quasi-experimental methods attempt to answer questions of causality.
  B) low-constraint methods attempt to answer questions of causality.
  C) unlike low-constraint methods, quasi-experiments always directly manipulate the independent variable.
  D) unlike low-constraint methods, quasi-experiments usually assign participants randomly to groups.

Question 2

The use of quasi-experimental designs is recommended
 
  A) only in situations in which full experimental controls can be used.
  B) in situations in which there is no causal question to be addressed.
  C) in situations in which full experimental controls cannot be employed, but where it is important to address a causal question.
  D) only in laboratory settings.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

k.lashomb

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

Answer: A

Answer to Question 2

Answer: C




k.lashomb

  • Sr. Member
  • ****
  • Posts: 346

 

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library